The global fertility supplements market is expected to reach USD 3.52 billion by 2030, according to a new report by Grand View Research, Inc. The market is estimated to expand at a CAGR of 8.1% during the forecast period and is driven by factors such as rising healthcare costs, changing lifestyles, and medical advancements. Furthermore, the rising trend of women delaying pregnancies and rising concerns over the ongoing decline in fertility rates will boost market growth.
Synthetic/blend of natural and synthetic fertility supplements accounted for the largest market share. These supplements contain a mix of vitamins and natural ingredients to assist in boosting fertility. Selenium, zinc, folic acid, vitamin C, vitamin B6, CoQ1, and Myo-Inositol are among the major synthetic ingredients that are in demand and are easily available.
The capsules, tablets, and soft gels were the prominent product segments in the market. Capsules held a major share in 2022 owing to microencapsulation in the health and wellness industry. It ensures the controlled release and quick absorption of finished products and helps protect sensitive compounds such as polyphenols or probiotics. This is expected to prompt manufacturers to opt for capsule dosage forms over the forecast period. However, high prices incurred during the blistering packaging method are projected to refrain manufacturers from using capsule formulation over the forecast period.
Tablets are highly used because of their cost-effectiveness. Quality tablets and supplements largely use excipients which assist in quicker absorption and disintegration of tablets. Moreover, the natural coating provides better dissolution, while there are some other factors that determine the absorption based on efficacy and quality. All these factors are expected to drive the demand for tablet-type fertility supplements in the forecast period.
The use of plant-derived products has risen globally due to the increasing vegan population and emphasis on reducing the risk of side effects when consuming supplements. This trend will bode well for natural fertility supplements over the forecast period. According to an article published by the World Health Organization in May 2023, approximately 40% of the pharmaceutical products today are drawn from nature and traditional knowledge.
Request a free sample copy or view report summary: Fertility Supplements Market Report
Synthetic/Blend of Natural and synthetic fertility supplements dominated the market, having accounted for a revenue share of 89.1% in 2023.These supplements contain a mix of vitamins and natural ingredients to assist in boosting fertility. Selenium, zinc, folic acid, vitamin C, vitamin B6, CoQ1, and Myo-Inositol are among the major synthetic ingredients that are in demand and are easily available.
Capsule-based fertility supplements dominated the market, having accounted for a revenue share of 39.9% in 2023. Capsules offer consumers a convenient and precise way to deliver a consistent dose of ingredients. Furthermore, capsules eliminate the need for measuring and mixing, saving time and simplifying the consumption process. Hence, capsules will continue to remain the dominant product type in the fertility supplements market during the forecast period.
North America dominated the market for fertility supplements and accounted for a 35.6% share of the global revenue in 2023. Due to the rising rate of infertility and increased public awareness of general health, North America is predicted to experience significant growth over the forecast period.
Grand View Research has segmented the global fertility supplements market on the basis of ingredient type, product type, end-user, distribution channel, and region:
Fertility SupplementsIngredient Type Outlook (Revenue, USD Million, 2017 - 2030)
Natural
Synthetic/ Blend of Natural & Synthetic
Fertility SupplementsProduct Outlook (Revenue, USD Million, 2017 - 2030)
Capsules
Tablets
Soft Gels
Powders
Liquids
Fertility SupplementsEnd-user Outlook (Revenue, USD Million, 2017 - 2030)
Men
Women
Fertility SupplementsDistribution Channel Outlook (Revenue, USD Million, 2017 - 2030)
OTC
Prescribed
Fertility SupplementsRegional Outlook (Revenue, USD Million, 2017 - 2030)
North America
U.S.
Canada
Mexico
Europe
U.K.
Germany
Italy
France
Asia Pacific
China
Japan
India
Central & South America
Brazil
Argentina
Middle East & Africa
South Africa
Saudi Arabia
List of Key Players in the Fertility Supplements Market
Fairhaven Health
Coast Science
Lenus Pharma GesmbH
Active Bio Life Science GmbH
Orthomol
Exeltis USA, Inc.
Bionova
Fertility Nutraceuticals LLC
Vitabiotics Ltd.
extreme V, Inc.
Xena Bio Herbals Pvt. Ltd.
Gonadosan Distribution GmbH (Fertilovit)
Innovamed Ltd. (Amino Expert)
Babystart Ltd.
Crown Nutraceuticals
Sal Nature LLC
Yadtech
Prega News
PlusPlus Lifesciences LLP
Eu Natural
"The quality of research they have done for us has been excellent..."